Michigan State University
Mechanistic and functional studies of zinc (II) activation of C-peptide and its effect on red blood cell metabolism
Abstract
dc:descriptionABSTRACT MECHANISTIC AND FUNCTIONAL STUDIES OF ZINC (II) ACTIVATION OF C-PEPTIDE AND ITS EFFECT ON RED BLOOD CELL METABOLISM By Wathsala Medawala C-peptide, a 31 amino acid peptide co-secreted with insulin from β-cells in the pancreas, has long been considered a by-product of insulin synthesis. Later it was discovered that C-peptide could ameliorate diabetic complications such as neuropathy, nephropathy, retinopathy and microvascular disease. However, the molecular mechanism behind the effects of C-peptide is not yet completely understood. The effect of C-peptide on the microcirculation is important, because problems in the circulation have been linked to other diabetic complications. C-peptide improves the microcirculation by increasing endothelial-derived nitric oxide (NO), red blood cell (RBC) deformability and Na<super>+</super>/K<super>+</super>-ATPase activity. C-peptide increases glucose utilization and ATP release from RBCs and endothelial cells. ATP is a stimulus for the production of endothelial-derived NO, which is a known vasodilator. Therefore, the C-peptide mediated increase in RBC-derived ATP release can lead to the improvement of blood flow.C-peptide alone did not increase RBC-derived ATP release. The presence of a metal ion such as Zn<super>2+</super> was needed to elicit this response. However, the role of Zn<super>2+</super> in C-peptide activity is not fully understood. A fluorescence based study was used to investigate the binding of Zn<super>2+</super> to C-peptide. Results indicate that C-peptide binds one Zn<super>2+</super> ion and has a binding constant of 1.02 x 10<super>7</super> M<super>-1</super> with Zn<super>2+</super> at pH 5.5, which is the pH inside a mature β-cell granule. At physiological pH of 7.4, C-peptide binds with two Zn<super>2+</super> ions and has a binding constant of 7.99 x 10<super>6</super> M<super>-1</super>. This indicates that C-peptide may bind with Zn<super>2+</super> inside the β-cell granule and release Zn<super>2+</super> upon entering the blood stream. Circular dichroism studies suggest that a 1:1 Zn<super>2+</super> to C-peptide ratio elicits a decrease in the randomness of the peptide chain, which is lost at higher Zn<super>2+</super> to C-peptide ratios.Five single amino acid peptide mutants of C-peptide were used to study the effect of the acidic amino acid residues on Zn<super>2+</super> binding. Substitution of glutamate residues at positions 27, 11 and 3 decreased the Zn<super>2+</super> binding to C-peptide by ~50%, agreeing with the activity of these mutants in other bio-assays. Several studies have indicated the necessity of insulin for C-peptide activity. The Zn<super>2+</super> that available with insulin hexamers may be responsible for activation of C-peptide. Using a RBC-derived ATP assay, it was shown that Zn<super>2+</super> added in the form of Zn-insulin activates C-peptide, as observed by the increase in ATP release. The C-peptide interaction with RBCs was studied using an ELISA. Zn<super>2+</super>-activated C-peptide bound to RBCs in a dose dependent manner, 2 pmol of Zn<super>2+</super>-activated C-peptide binding to 1 mL of 7% red blood cell sample at saturation (~1500 molecules/ cell). The interaction did not change significantly even in the absence of Zn<super>2+</super>. However, Zn<super>2+</super> uptake in RBCs was observed only in the presence of C-peptide, indicating a possible role for C-peptide as a Zn<super>2+</super> carrier. One argument against C-peptide being a potential medication is that patients with type 2 diabetes develop the complications of the disease despite having circulating C-peptide. Red blood cells incubated in high glucose (>10 mM), showed lower interaction with Zn<super>2+</super>-activated C-peptide and lower ATP release, showing that patients with uncontrolled blood glucose levels might show resistance to the action of the peptide. Also, the exposure of Zn<super>2+</super>-activated C-peptide to serum albumin and mM levels of other cations and anions decreases its activity. Taken together, the work presented in this dissertation explains the role of Zn<super>2+</super> in C-peptide action and how reproducible results may be obtained in C-peptide clinical trials.
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Medawala, Wathsala
- Contributors dc:contributor
-
- Spence, Dana M.
- Reid, Gavin
- Jones, Daniel
- Smith, Mitch
Subjects
dc:subject × 3Rights
dc:rights- Statement dc:rights
-
- In Copyright
- Language dc:language
- English
Identifiers
dc:identifier.*- Identifier
-
etd:589
isbn:9781124858876
isbn:1124858873
oclc:931743348
umi:3469659
local:Medawala_grad.msu_0128D_10734 - OAI record oai:identifier
- https://d.lib.msu.edu/oai?verb=GetRecord&metadataPrefix=oai_dc&identifier=oai%3Ad.lib.msu.edu%3Aetd_589